Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 4loq | SB4 | Mitogen-activated protein kinase 14 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 4loq | SB4 | Mitogen-activated protein kinase 14 | / | 1.000 | |
| 4lop | SB4 | Mitogen-activated protein kinase 14 | / | 0.763 | |
| 3hl7 | I47 | Mitogen-activated protein kinase 14 | / | 0.524 | |
| 3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.465 | |
| 4loo | SB4 | Mitogen-activated protein kinase 14 | / | 0.464 | |
| 3nww | 3NW | Mitogen-activated protein kinase 14 | / | 0.454 | |
| 2xik | J60 | Serine/threonine-protein kinase 25 | 2.7.11.1 | 0.447 | |
| 3kf7 | L9G | Mitogen-activated protein kinase 14 | / | 0.447 | |
| 3bgb | LJG | Gag-Pol polyprotein | 3.4.23.16 | 0.446 | |
| 3ttp | 017 | Gag-Pol polyprotein | 3.4.23.16 | 0.446 | |
| 1k6c | MK1 | Gag-Pol polyprotein | 3.4.23.16 | 0.445 | |
| 3sm2 | 478 | Putative gag-pro-pol polyprotein | / | 0.445 | |
| 4zse | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.445 | |
| 5ar4 | SB2 | Receptor-interacting serine/threonine-protein kinase 2 | 2.7.11.1 | 0.445 | |
| 1c6y | MK1 | Protease | / | 0.444 | |
| 3nu4 | 478 | Gag-Pol polyprotein | 3.4.23.16 | 0.444 | |
| 1xl5 | 190 | Gag-Pol polyprotein | 3.4.23.16 | 0.443 | |
| 1jld | 0PP | Gag-Pol polyprotein | / | 0.442 | |
| 2he5 | NDP | Aldo-keto reductase family 1 member C21 | 1.1.1 | 0.442 | |
| 3liv | E16 | Protease | / | 0.442 | |
| 2g26 | 3LG | Renin | 3.4.23.15 | 0.441 | |
| 2gjl | FMN | Nitronate monooxygenase | 1.13.12.16 | 0.440 | |
| 3nwx | KVS | Gag-Pol polyprotein | 3.4.23.16 | 0.440 | |
| 3t11 | 3T1 | Gag-Pol polyprotein | 3.4.23.16 | 0.440 |